Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Stem Cell Culture01:17

Stem Cell Culture

4.6K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
4.6K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Embryonic Stem Cells00:58

Embryonic Stem Cells

25.9K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
25.9K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.5K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.5K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inter-Rater Reliability Of Assigning A Pediatric Appendicitis Grade: An International Multicenter Study By The Canadian Consortium For Research In Pediatric Surgery (CanCORPS).

Annals of surgery open : perspectives of surgical history, education, and clinical approaches·2026
Same author

Malignant transformation of sacrococcygeal teratoma versus presacral teratoma in Currarino syndrome: Results of 'The SCT-study'.

Journal of pediatric surgery·2026
Same author

Neonatal and early infant intussusception: a 24-year retrospective review from a tertiary referral center.

Pediatric radiology·2026
Same author

Embryonic Gut Explant Model for Enteric Neural Crest Cells Migration.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Embryonic Gut Enteric Neural Crest Cells Derived Neurospheres.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Progress in cell therapies for neonatal conditions: Proceedings of the Third Neonatal Cell Therapies Symposium (2025).

Pediatric research·2026
Same journal

Biologic modulation of ineffective erythropoiesis in thalassemia: mechanisms, clinical practice, and future targets.

Expert opinion on biological therapy·2026
Same journal

TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

Expert opinion on biological therapy·2026
Same journal

Type 2 inflammation and biologics: a twenty-year journey.

Expert opinion on biological therapy·2026
Same journal

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Expert opinion on biological therapy·2026
Same journal

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with primary focus on rituximab and belimumab.

Expert opinion on biological therapy·2026
Same journal

Biological drugs for the treatment of children with atopic dermatitis.

Expert opinion on biological therapy·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

3.5K

Stem cells as a potential therapy for necrotizing enterocolitis.

Simon Eaton1, Augusto Zani, Agostino Pierro

  • 1UCL Institute of Child Health , 30 Guilford Street, London , UK s.eaton@ucl.ac.uk.

Expert Opinion on Biological Therapy
|October 25, 2013
PubMed
Summary
This summary is machine-generated.

Amniotic fluid stem (AFS) cells show promise in treating necrotizing enterocolitis (NEC), a serious condition in premature infants. Further research is needed to confirm their clinical effectiveness for NEC therapy.

More Related Videos

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

7.2K
In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis
09:11

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

Published on: June 8, 2022

2.2K

Related Experiment Videos

Last Updated: May 6, 2026

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

3.5K
A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

7.2K
In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis
09:11

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

Published on: June 8, 2022

2.2K

Area of Science:

  • Neonatal medicine
  • Gastroenterology
  • Stem cell biology

Background:

  • Necrotizing enterocolitis (NEC) is a critical gastrointestinal disease affecting neonates, particularly premature infants, leading to significant morbidity and mortality.
  • Current treatments for NEC are primarily supportive, highlighting the need for targeted therapies to address intestinal damage.

Purpose of the Study:

  • To explore the therapeutic potential of amniotic fluid stem (AFS) cells in managing necrotizing enterocolitis (NEC).
  • To investigate the efficacy of AFS cells in an animal model of NEC and elucidate their mechanism of action.
  • To compare the effects of AFS cells with bone marrow mesenchymal stem cells for potential NEC treatment.

Main Methods:

  • Introduction to NEC and its impact on intestinal epithelia.
  • Description of amniotic fluid stem (AFS) cells and their properties.
  • Presentation of data from an animal model of NEC treated with AFS cells, including mechanistic insights.

Main Results:

  • AFS cells demonstrated beneficial effects in a rodent model of NEC.
  • A potential mechanism for AFS cell action in NEC was described.
  • Comparative analysis of AFS cells and bone marrow mesenchymal stem cells in the context of NEC.

Conclusions:

  • Current findings suggest stem cells, including AFS cells, can impact NEC in preclinical models.
  • Significant challenges remain, including model limitations and the need for longitudinal evaluation, before clinical trials.
  • These results open new avenues for research into novel prevention and therapy strategies for NEC.